Drug Essentials: Epothilones.
- Published in:
- 2008
- By:
- Publication type:
- Product Review
Works matching DE "BRISTOL-Myers Squibb Co."
Results: 290
1
2
Cetuximab Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 11, p. 1402
- Publication type:
- Article
3
Announcements.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 8, p. 1017
- Publication type:
- Article
4
Data Available From Cetuximab Study in First-Line Treatment of Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 6, p. 707
- Publication type:
- Article
5
Cetuximab Survival Data Available From Study in First-Line Treatment of Advanced Head and Neck Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 5, p. 616
- Publication type:
- Article
6
ANALYSIS TOOL RELEASED BY WORLD RESOURCES INSTITUTE.
- Published in:
- Computer Systems Science & Engineering, 2006, v. 21, n. 3, p. 6
- Publication type:
- Article
7
January News Briefs.
- Published in:
- Bio-IT World, 2012, v. 11, n. 1, p. 1
- Publication type:
- Article
8
Taking the High Road.
- Published in:
- Bio-IT World, 2010, v. 9, n. 4, p. 20
- By:
- Publication type:
- Article
9
Briefs.
- Published in:
- Bio-IT World, 2010, v. 9, n. 3, p. 9
- Publication type:
- Article
10
BMS Seeks to Become 'Next-Generation Pharma.'.
- Published in:
- Bio-IT World, 2008, v. 7, n. 8, p. 11
- By:
- Publication type:
- Article
11
Iconix Seals Two Major Tox Deals.
- Published in:
- Bio-IT World, 2004, v. 3, n. 3, p. 12
- By:
- Publication type:
- Article
12
DISCOVERY AND DEVELOPMENT PARTICIPANTS.
- Published in:
- 2003
- Publication type:
- Other
13
Immunotherapy for metastatic melanoma approved.
- Published in:
- Nature Reviews Immunology, 2011, v. 11, n. 5, p. 300, doi. 10.1038/nri2981
- By:
- Publication type:
- Article
14
The 2005 Tour of Hope.
- Published in:
- Nursing Education Perspectives (National League for Nursing), 2005, v. 26, n. 5, p. 322
- Publication type:
- Article
15
Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE).
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 4, p. 559, doi. 10.1007/s40744-019-00174-7
- By:
- Publication type:
- Article
16
Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 2, p. 217, doi. 10.1007/s40744-019-0149-3
- By:
- Publication type:
- Article
17
PRODUCT NEWS.
- Published in:
- British Journal of Healthcare Management, 2007, v. 13, n. 1, p. 28
- Publication type:
- Article
18
THE WEATHERVANE.
- Published in:
- Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 1, p. 34
- Publication type:
- Article
19
Collaboration in Development of New Drugs.
- Published in:
- Production & Operations Management, 2021, v. 30, n. 11, p. 3943, doi. 10.1111/poms.13377
- By:
- Publication type:
- Article
20
newsbites.
- Published in:
- ComputerWorld Hong Kong, 2008, v. 25, n. 9, p. 6
- Publication type:
- Article
21
TGA approves metastatic melanoma drug.
- Published in:
- Australian Journal of Pharmacy, 2011, v. 92, n. 1096, p. 56
- Publication type:
- Article
22
Biomedical briefing.
- Published in:
- Nature Medicine, 2012, v. 18, n. 8, p. 1162, doi. 10.1038/nm0812-1162
- Publication type:
- Article
23
New diabetes drugs go beyond insulin to flush out excess sugar.
- Published in:
- Nature Medicine, 2011, v. 17, n. 6, p. 636, doi. 10.1038/nm0611-636a
- By:
- Publication type:
- Article
24
NIH sues BMS over missing drug royalties.
- Published in:
- Nature Medicine, 2000, v. 6, n. 12, p. 1302, doi. 10.1038/82079
- By:
- Publication type:
- Article
25
BMS offers some relief for Africa's AIDS crisis.
- Published in:
- Nature Medicine, 1999, v. 5, n. 6, p. 599, doi. 10.1038/9433
- By:
- Publication type:
- Article
26
Bruntland makes waves in her first six months at the WHO.
- Published in:
- Nature Medicine, 1999, v. 5, n. 3, p. 249, doi. 10.1038/6435
- By:
- Publication type:
- Article
27
Researchers benefit at BMS award night.
- Published in:
- Nature Medicine, 1999, v. 5, n. 1, p. 9, doi. 10.1038/4682
- By:
- Publication type:
- Article
28
New drugs.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 3, p. 208
- Publication type:
- Article
29
Labeling changes issued for antibiotic used in UTIs.
- Published in:
- Urology Times, 2006, v. 34, n. 4, p. 6
- Publication type:
- Article
30
Injectable antibiotic treats UTIs.
- Published in:
- Urology Times, 1997, v. 25, n. 1, p. 44
- Publication type:
- Article
31
Patent expiries in HIV -- Generics to take centre stage?
- Published in:
- Journal of Generic Medicines, 2005, v. 3, n. 1, p. 85, doi. 10.1057/palgrave.jgm.4940103
- Publication type:
- Article
32
Synthesis of stable‐isotope‐labeled N‐(3‐dimethylaminopropyl)‐N′‐ethylcarbodiimide and N‐(3‐dimethylaminopropyl)‐N′‐ethylurea.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 13, p. 526, doi. 10.1002/jlcr.3877
- By:
- Publication type:
- Article
33
Help for Rheumatoid Arthritis.
- Published in:
- Medical Update, 2004, v. 29, n. 12, p. 7
- Publication type:
- Article
34
The Universal Patient Language: A set of resources and tools to design patient communications that support better health literacy.
- Published in:
- Information Services & Use, 2019, v. 39, n. 1/2, p. 69, doi. 10.3233/ISU-180031
- By:
- Publication type:
- Article
35
Afghanistan: the 'worst' place in the world for pregnant women.
- Published in:
- British Journal of Midwifery, 2010, v. 18, n. 7, p. 447, doi. 10.12968/bjom.2010.18.7.48785
- By:
- Publication type:
- Article
36
Class Actions, Jurisdiction, and Principle in Doctrinal Design.
- Published in:
- Brigham Young University Law Review, 2019, v. 2019, n. 6, p. 1511
- By:
- Publication type:
- Article
37
Ipilimumab: Melanoma and beyond.
- Published in:
- Journal of Pharmacy & Bioallied Sciences, 2011, v. 3, n. 4, p. 546, doi. 10.4103/0975-7406.90113
- By:
- Publication type:
- Article
38
Business digest.
- Published in:
- Chemistry & Industry, 2013, v. 77, n. 5, p. 19
- Publication type:
- Article
39
Business digest.
- Published in:
- Chemistry & Industry, 2012, v. 76, n. 8, p. 20, doi. 10.1002/cind.7608_4.x
- Publication type:
- Article
40
Companies, technology & environment.
- Published in:
- Chemistry & Industry, 2011, n. 7, p. 13
- By:
- Publication type:
- Article
41
BMS grabs Zymo.
- Published in:
- Chemistry & Industry, 2010, n. 18, p. 7
- Publication type:
- Article
42
US pharma sector sees recovery in Q4 figures.
- Published in:
- Chemistry & Industry, 2010, n. 4, p. 12
- By:
- Publication type:
- Article
43
Business digest.
- Published in:
- Chemistry & Industry, 2009, n. 17, p. 13
- By:
- Publication type:
- Article
44
US pharma flourishes...
- Published in:
- Chemistry & Industry, 2009, n. 16, p. 12
- By:
- Publication type:
- Article
45
Lilly acquires ImClone for $6.5bn.
- Published in:
- Chemistry & Industry, 2008, n. 19, p. 5
- By:
- Publication type:
- Article
46
Pharma has good first half.
- Published in:
- Chemistry & Industry, 2008, n. 15, p. 5
- By:
- Publication type:
- Article
47
Pharma briefs.
- Published in:
- Chemistry & Industry, 2008, n. 9, p. 7
- Publication type:
- Article
48
Tough times for pharma.
- Published in:
- Chemistry & Industry, 2008, n. 3, p. 6
- By:
- Publication type:
- Article
49
New global giant on the horizon.
- Published in:
- Chemistry & Industry, 2007, n. 3, p. 4
- By:
- Publication type:
- Article
50
BMS board sacks chief.
- Published in:
- Chemistry & Industry, 2006, n. 19, p. 6
- By:
- Publication type:
- Article